Quest Diagnostics Inc
NYSE:DGX
Quest Diagnostics Inc
Revenue
Quest Diagnostics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Chemed Corp
NYSE:CHE
|
Revenue
$2.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
Quest Diagnostics Inc
Revenue Breakdown
Breakdown by Geography
Quest Diagnostics Inc
Breakdown by Segments
Quest Diagnostics Inc
Total Revenue:
9.3B
USD
|
Dis Business:
9B
USD
|
All Other Operating Segments:
276m
USD
|
See Also
What is Quest Diagnostics Inc's Revenue?
Revenue
9.3B
USD
Based on the financial report for Mar 31, 2024, Quest Diagnostics Inc's Revenue amounts to 9.3B USD.
What is Quest Diagnostics Inc's Revenue growth rate?
Revenue CAGR 10Y
3%
Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for Quest Diagnostics Inc have been -4% over the past three years , 4% over the past five years , and 3% over the past ten years .